EVP, Drug Development
Wed, Apr 13, 2022
Apr 13
2,012 shares @ $6.07
Decreased holdings by -15.60%
9th largest trade (out of 63)
Cluster Buy
Trade made by an officer
Part of a cluster of 5 transactions by 3 insiders
Price 38% below 200-day moving average